Related Experiment Video
Updated: Jun 6, 2026

Performing Human Skeletal Muscle Xenografts in Immunodeficient Mice
Published on: September 16, 2019
Growth hormone therapy in patients with short stature homeobox-gene (SHOX) deficiency
L Iughetti1, S Madeo, B Predieri
1Department of Pediatrics, University of Modena and Reggio Emilia, Modena, Italy. iughetti.lorenzo@unimore.it
Abstract:
Short stature homeobox (SHOX) gene is located in the pseudoautosomal region 1 on the distal end of the X and Y chromosomes at Xp22.3 and Yp11.3. The haploinsufficiency of SHOX is correlated with short stature, Leri-Weill dyschondrosteosis, and Langer mesomelic dysplasia. Subjects with Turner syndrome (TS) present a SHOX haploinsufficiency that appears to be substantially responsible for their short stature. Several studies have shown a positive response to GH therapy in patients with TS. Short children with SHOX haploinsufficiency do not spontaneously catch up to attain a normal final height. Considering the positive effects obtained in patients with TS, GH therapy has been proposed for short stature due to isolated SHOX haploinsufficiency. The aim of this paper is to summarize the current data on GH administration in patients with SHOX haploinsufficiency. The conclusion is that GH therapy, at the same dosage used in patients with TS, induces a sustained catch-up growth and a height velocity and adult height gain in short patients with SHOX haploinsufficiency.
Related Concept Videos
Nature and Nurture
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Gene Therapy
Gene Therapy
Hedgehog Signaling Pathway
Cellular Adaptation II: Hypertrophy
